There are 2789 resources available
201TiP - Evaluation of the feasibility of ultrasound-guided clipping of suspicious intramammary lesions in primary breast cancer patients receiving neoadjuvant therapy (Ultra3Detect)
Presenter: Efstathia Vlachou
Session: ePoster Display
203P - Randomized study of single-agent metronomic versus weekly oral vinorelbine (VNR) as first-line chemotherapy in patients with HR+/HER2- advanced breast cancer
Presenter: Marina Cazzaniga
Session: ePoster Display
204P - Predictive factors for relapse in triple-negative breast cancer (TNBC) patients without pathologic complete response (PCR)
Presenter: Marta Venturelli
Session: ePoster Display
49P - A phase II trial of nivolumab and gemcitabine and S-1 as the first-line treatment in patients with advanced biliary tract cancer
Presenter: Nai-Jung Chiang
Session: ePoster Display
51P - Pooled analysis safety profile of futibatinib in patients with advanced solid tumors, including intrahepatic cholangiocarcinoma (iCCA)
Presenter: Funda Meric-Bernstam
Session: ePoster Display
52P - Assessment of futibatinib exposure–response (E–R) relationships in patients with advanced solid tumors, including cholangiocarcinoma (CCA)
Presenter: Antoine Hollebecque
Session: ePoster Display
53P - FGFR2 fusion and/or rearrangement profiling in Chinese patients with intrahepatic cholangiocarcinoma
Presenter: Xiao-Wu Huang
Session: ePoster Display
37P - Interleukin-1β effect on the efficacy of cytostatic drugs in vitro
Presenter: Anna Malkova
Session: ePoster Display